INmune Bio Inc. Share Price

INmune Bio Inc. Share Price

NASDAQ: INMB | Micro Cap
$1.59
+$0.06 (3.92%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

INmune Bio Inc. Stock Performance

Open
$1.55
Prev. Close
$1.53
Circuit Range
N/A
Day Range
$1.55 - $1.65
Year Range
$1.10 - $2.60
Volume
12,083
Average Traded
$1.60

INmune Bio Inc. Share Price Today

As of 30 October 2026, INmune Bio Inc.'s share price is $1.59. The stock opened at $1.55, compared to its previous close of $1.53. During today's trading session, INmune Bio Inc.'s share price traded between $1.55 and $1.65, with an average price of $1.60. Over the past 52 weeks, the stock has recorded a high of $2.60 and a low of $1.10. In terms of performance, INmune Bio Inc.'s share price has risen by 11.19% over the last six months and is down 13.11% on a year-on-year basis.

INmune Bio Inc. Share Price Chart

Line chart of the INmune Bio Inc. price trend over the selected period. The price rose overall, ranging from 1.55 to 1.65, ending at 1.59.
$1.55$1.65
L
Show Current Price
H

INmune Bio Inc. Stock Fundamentals & Key Indicators

Market Cap
$39.36M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.66
Revenue (TTM)
$50.00M
Return On Equity (TTM)
-90.44%
Profit Margin
-91860.00%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
80.37%

INmune Bio Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$6.47-$5.26-$5.41-$1.27
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A18.70%-2.85%76.52%

INmune Bio Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.37$0.16$0.01$0.05
Net Profit-$27.30-$30.01-$42.08-$45.93
Net Profit Margin-7378.38%-18756.25%-420800.00%-91860.00%
Income ChangeN/A-9.93%-40.22%-9.15%

About INmune Bio Inc.

INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.

INmune Bio Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$1.95
$1.59
-18.46%
Sep 2026
$2.25
$1.95
-19.09%
Aug 2026
$1.80
$2.41
+36.93%
Jul 2026
$1.64
$1.76
+7.98%
Jun 2026
$1.38
$1.63
+15.60%
May 2026
$1.44
$1.41
-1.40%
Apr 2026
$1.19
$1.43
+26.55%
Mar 2026
$1.27
$1.13
-13.08%
Feb 2026
$1.53
$1.30
-18.24%
Jan 2026
$1.58
$1.59
+2.25%
Dec 2025
$1.67
$1.55
-10.63%
Nov 2025
$1.85
$1.74
-4.92%

INMB Share Price FAQs